Please login to the form below

Not currently logged in
Email:
Password:

UDG Healthcare’s Chris Corbin to retire

CEO of Ashfield Commercial & Medical Services to step down in 2019

Ashfield Chris CorbinChief executive officer of Ashfield Commercial & Medical Services Chris Corbin is to retire from his post in April 2019.

Corbin will transfer to the role of chairman of Ashfield - part of the UDG Healthcare group - once his successor has been appointed in order to facilitate a phased transition of responsibilities over the next two years.

Corbin co-founded Ashfield Healthcare, a UK contract sales organisation, with his wife Samantha Corbin in 1996, and the firm became part of the UDG group in 2000.

He has served as a main board director of UDG Healthcare since then, growing Leicester-based Ashfield to encompass eight units with 5,500 employees across 20 countries worldwide.

Brendan McAtamney, chief executive of UDG Healthcare, said: “I would like to thank Chris for his substantial contribution to the success of both the group and Ashfield since joining us in 2000.

“Under his leadership, Ashfield has developed into a leading international healthcare services organisation and a key division of the group.

“We will work closely with Chris over the next two and a half years to ensure a professional transition process and thereafter wish him the very best in retirement.”

3rd October 2016

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics